# AnnotationID, ClassType, DocCharOnset(incl), DocCharOffset(excl), Text, Meta, Instances
0, Journal, 0, 14, "Eye ( Lond ) .", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasJournal> \"Eye ( Lond ) .\"."
1, PublicationYear, 15, 19, "2016", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasPublicationYear> \"2016\"."
2, Title, 107, 251, "Ocular hypotensive effect of fixed - combination brinzolamide / brimonidine adjunctive to a prostaglandin analog : a randomized clinical trial .", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasTitle> \"Ocular hypotensive effect of fixed - combination brinzolamide / brimonidine adjunctive to a prostaglandin analog : a randomized clinical trial .\"."
6, Brinz/BrimoFC, 136, 182, "fixed - combination brinzolamide / brimonidine", "", 
3, Brinzolamide, 156, 168, "brinzolamide", "", 
4, Brimonidine, 171, 182, "brimonidine", "", 
92828, ProstaglandinAnalogs, 199, 219, "prostaglandin analog", "", 
5, Randomized, 224, 234, "randomized", "", 
7, Author, 252, 263, "Fechtner RD", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasAuthor> \"Fechtner RD\"."
8, Author, 272, 280, "Myers JS", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasAuthor> \"Myers JS\"."
9, Author, 289, 300, "Hubatsch DA", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasAuthor> \"Hubatsch DA\"."
10, Author, 309, 318, "Budenz DL", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasAuthor> \"Budenz DL\"."
11, Author, 327, 337, "DuBiner HB", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasAuthor> \"DuBiner HB\"."
12, USA, 453, 456, "USA", "", "<http://ctro/data#Population_95328> <http://ctro/data#hasCountry> <http://ctro/data#USA>."
13, USA, 506, 509, "USA", "", 
14, USA, 565, 568, "USA", "", 
15, USA, 657, 660, "USA", "", 
16, USA, 704, 707, "USA", "", 
92796, ObjectiveDescription, 710, 936, "PurposeTo determine whether intraocular pressure ( IOP ) lowering with fixed - combination brinzolamide / brimonidine ( BBFC ) adjunctive to a prostaglandin analog ( PGA ) was superior to that of vehicle + PGA in patients with", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasObjectiveDescription> \"PurposeTo determine whether intraocular pressure ( IOP ) lowering with fixed - combination brinzolamide / brimonidine ( BBFC ) adjunctive to a prostaglandin analog ( PGA ) was superior to that of vehicle + PGA in patients with\"."
123, IOP, 738, 758, "intraocular pressure", "", 
124, IOP, 761, 764, "IOP", "", 
125, Brinzolamide, 801, 813, "brinzolamide", "", "<http://ctro/data#Medication_95337> <http://ctro/data#hasDrug> <http://ctro/data#Brinzolamide>."
127, Brinz/BrimoFC, 801, 827, "brinzolamide / brimonidine", "", 
126, Brimonidine, 816, 827, "brimonidine", "", "<http://ctro/data#Medication_95344> <http://ctro/data#hasDrug> <http://ctro/data#Brimonidine>."
128, Brinz/BrimoFC, 830, 834, "BBFC", "", 
92829, ProstaglandinAnalogs, 853, 873, "prostaglandin analog", "", "<http://ctro/data#Medication_95367> <http://ctro/data#hasDrug> <http://ctro/data#ProstaglandinAnalogs>."
92830, ProstaglandinAnalogs, 876, 879, "PGA", "", 
92824, Vehicle, 906, 913, "vehicle", "", "<http://ctro/data#Medication_95381> <http://ctro/data#hasDrug> <http://ctro/data#Vehicle>."
92831, ProstaglandinAnalogs, 916, 919, "PGA", "", 
130, OpenAngleGlaucoma, 937, 958, "open - angle glaucoma", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OpenAngleGlaucoma>."
92818, ObjectiveDescription, 937, 1046, "open - angle glaucoma or ocular hypertension who were inadequately controlled with PGA monotherapyMethodsThis", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasObjectiveDescription> \"open - angle glaucoma or ocular hypertension who were inadequately controlled with PGA monotherapyMethodsThis\"."
150, OcularHypertension, 962, 981, "ocular hypertension", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#analysesHealthCondition> <http://ctro/data#OcularHypertension>."
131, Precondition, 991, 1023, "inadequately controlled with PGA", "", "<http://ctro/data#Population_95328> <http://ctro/data#hasPrecondition> \"inadequately controlled with PGA\"."
92832, ProstaglandinAnalogs, 1020, 1023, "PGA", "", 
20, Duration, 1047, 1055, "6 - week", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTduration> \"6 - week\"."
21, Multicenter, 1058, 1069, "multicenter", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTDesign> <http://ctro/data#Multicenter>."
22, Randomized, 1072, 1082, "randomized", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTDesign> <http://ctro/data#Randomized>."
23, DoubleBlind, 1085, 1100, "double - masked", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTDesign> <http://ctro/data#DoubleBlind>."
24, Parallel, 1103, 1119, "parallel - group", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTDesign> <http://ctro/data#Parallel>."
25, Multicenter, 1143, 1160, "30 clinical sites", "", 
26, USA, 1168, 1181, "United States", "", 
92819, Precondition, 1241, 1379, "adults with open - angle glaucoma or ocular hypertension and with mean IOP ≥ 21 and < 32   mm   Hg , whereas receiving an open - label PGA", "", "<http://ctro/data#Population_95328> <http://ctro/data#hasPrecondition> \"adults with open - angle glaucoma or ocular hypertension and with mean IOP ≥ 21 and < 32   mm   Hg , whereas receiving an open - label PGA\"."
28, OpenAngleGlaucoma, 1253, 1274, "open - angle glaucoma", "", 
29, OcularHypertension, 1278, 1297, "ocular hypertension", "", 
30, Mean, 1307, 1311, "mean", "", 
31, IOP, 1312, 1315, "IOP", "", 
32, mmHg, 1332, 1339, "mm   Hg", "", 
144, OpenLabel, 1363, 1375, "open - label", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTDesign> <http://ctro/data#OpenLabel>."
92840, ProstaglandinAnalogs, 1376, 1379, "PGA", "", 
34, Latanoprost, 1382, 1393, "latanoprost", "", 
35, Bimatoprost, 1396, 1407, "bimatoprost", "", 
36, Travoprost, 1413, 1423, "travoprost", "", 
92820, DeliveryMethod, 1437, 1446, "instilled", "", "<http://ctro/data#DeliveryMethod_95341> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_95337> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_95341>. <http://ctro/data#DeliveryMethod_95348> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_95344> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_95348>. <http://ctro/data#DeliveryMethod_95371> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_95367> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_95371>. <http://ctro/data#DeliveryMethod_95385> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#DeliveryMethod>. <http://ctro/data#Medication_95381> <http://ctro/data#hasDeliveryMethod> <http://ctro/data#DeliveryMethod_95385>."
92841, ProstaglandinAnalogs, 1449, 1452, "PGA", "", 
37, Frequency, 1453, 1465, "once - daily", "", "<http://ctro/data#Intervention_95374> <http://ctro/data#hasFrequency> \"once - daily\"."
38, Randomized, 1493, 1506, "randomization", "", 
92823, Blind, 1510, 1516, "masked", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasCTDesign> <http://ctro/data#Blind>."
39, Brinz/BrimoFC, 1517, 1521, "BBFC", "", 
92825, Vehicle, 1525, 1532, "vehicle", "", 
92821, Blind, 1556, 1562, "Masked", "", 
92822, DeliveryMethod, 1579, 1588, "instilled", "", 
41, Frequency, 1589, 1602, "3 times daily", "", "<http://ctro/data#Intervention_95351> <http://ctro/data#hasFrequency> \"3 times daily\". <http://ctro/data#Intervention_95395> <http://ctro/data#hasFrequency> \"3 times daily\"."
42, Duration, 1607, 1614, "6 weeks", "", 
43, Frequency, 1640, 1652, "once - daily", "", 
92833, ProstaglandinAnalogs, 1666, 1669, "PGA", "", 
44, Mean, 1741, 1745, "mean", "", 
45, Diurnal_IOP, 1746, 1757, "diurnal IOP", "", 
161, TimePoint, 1771, 1775, "0800", "", 
162, TimePoint, 1778, 1782, "1000", "", 
163, TimePoint, 1785, 1789, "1500", "", 
164, TimePoint, 1796, 1800, "1700", "", 
165, TimePoint, 1824, 1830, "week 6", "", 
47, TimePoint, 1843, 1849, "week 6", "", "<http://ctro/data#Outcome_95418> <http://ctro/data#hasTimePoint> \"week 6\". <http://ctro/data#Outcome_95445> <http://ctro/data#hasTimePoint> \"week 6\"."
48, Mean, 1852, 1856, "mean", "", "<http://ctro/data#Mean_95415> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://ctro/data#Mean>. <http://ctro/data#Endpoint_95413> <http://ctro/data#hasAggregationMethod> <http://ctro/data#Mean_95415>."
49, Diurnal_IOP, 1857, 1868, "diurnal IOP", "", "<http://ctro/data#Endpoint_95413> <http://ctro/data#hasEndoPointDescription> <http://ctro/data#Diurnal_IOP>."
50, Brinz/BrimoFC, 1874, 1878, "BBFC", "", 
92834, ProstaglandinAnalogs, 1881, 1884, "PGA", "", 
92826, Vehicle, 1905, 1912, "vehicle", "", 
92835, ProstaglandinAnalogs, 1915, 1918, "PGA", "", 
55, ResultMeasuredValue, 1921, 1927, "17 . 1", "", "<http://ctro/data#Outcome_95418> <http://ctro/data#hasResultMeasuredValue> \"17 . 1\"."
57, SdErrorResValue, 1930, 1935, "0 . 4", "", "<http://ctro/data#Outcome_95418> <http://ctro/data#hasSdErrorResValue> \"0 . 4\"."
58, mmHg, 1938, 1945, "mm   Hg", "", "<http://ctro/data#Endpoint_95413> <http://ctro/data#hasBaselineUnit> <http://ctro/data#mmHg>."
56, ResultMeasuredValue, 1949, 1955, "20 . 5", "", "<http://ctro/data#Outcome_95445> <http://ctro/data#hasResultMeasuredValue> \"20 . 5\"."
59, SdErrorResValue, 1958, 1963, "0 . 4", "", "<http://ctro/data#Outcome_95445> <http://ctro/data#hasSdErrorResValue> \"0 . 4\"."
60, mmHg, 1966, 1973, "mm   Hg", "", 
176, DiffGroupAbsValue, 2005, 2012, "- 3 . 4", "", "<http://ctro/data#DiffBetweenGroups_95472> <http://ctro/data#hasDiffGroupAbsValue> \"- 3 . 4\"."
62, SdErrorDiff, 2015, 2020, "0 . 5", "", "<http://ctro/data#DiffBetweenGroups_95472> <http://ctro/data#hasStandardErrorDiff> \"0 . 5\"."
63, mmHg, 2023, 2030, "mm   Hg", "", 
64, PvalueDiff, 2033, 2045, "P < 0 . 0001", "", "<http://ctro/data#DiffBetweenGroups_95472> <http://ctro/data#hasPvalueDiff> \"P < 0 . 0001\"."
65, ConfIntervalDiff, 2048, 2103, "95 % confidence interval , - 4 . 5 to - 2 . 4   mm   Hg", "", "<http://ctro/data#DiffBetweenGroups_95472> <http://ctro/data#hasConfIntervalDiff> \"95 % confidence interval , - 4 . 5 to - 2 . 4   mm   Hg\"."
66, mmHg, 2096, 2103, "mm   Hg", "", 
67, Brinz/BrimoFC, 2108, 2112, "BBFC", "", 
92836, ProstaglandinAnalogs, 2115, 2118, "PGA", "", 
69, Mean, 2127, 2131, "mean", "", 
70, Diurnal_IOP, 2132, 2143, "diurnal IOP", "", 
71, Reduction, 2147, 2152, "5 . 7", "", "<http://ctro/data#Outcome_95481> <http://ctro/data#hasChangeValue> \"5 . 7\"."
72, mmHg, 2155, 2162, "mm   Hg", "", 
73, RelativeReduction, 2165, 2167, "25", "", "<http://ctro/data#Outcome_95481> <http://ctro/data#hasRelativeChangeValue> \"25\"."
74, IOP, 2190, 2193, "IOP", "", 
92837, ProstaglandinAnalogs, 2208, 2211, "PGA", "", 
76, ConclusionComment, 2226, 2356, "ConclusionsTherapy with BBFC produced an additive IOP - lowering effect compared with a PGA alone or in conjunction with vehicle .", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasConclusionComment> \"ConclusionsTherapy with BBFC produced an additive IOP - lowering effect compared with a PGA alone or in conjunction with vehicle .\"."
77, Brinz/BrimoFC, 2250, 2254, "BBFC", "", 
78, IOP, 2276, 2279, "IOP", "", 
92838, ProstaglandinAnalogs, 2314, 2317, "PGA", "", 
92827, Vehicle, 2347, 2354, "vehicle", "", 
81, ConclusionComment, 2357, 2481, "BBFC may provide an effective treatment option for patients receiving PGA monotherapy who require additional IOP reduction .", "", "<http://ctro/data#ClinicalTrial_95304> <http://ctro/data#hasConclusionComment> \"BBFC may provide an effective treatment option for patients receiving PGA monotherapy who require additional IOP reduction .\"."
82, Brinz/BrimoFC, 2357, 2361, "BBFC", "", 
92839, ProstaglandinAnalogs, 2427, 2430, "PGA", "", 
84, IOP, 2466, 2469, "IOP", "", 
85, PMID, 2543, 2551, "27367743", "", "<http://ctro/data#Publication_95293> <http://ctro/data#hasPMID> \"27367743\"."
86, ConflictInterest, 2609, 2719, "RDF has received consultant fees from Alcon and Bausch & Lomb , and research support from Alcon and Allergan .", "", 
87, ConflictInterest, 2720, 2934, "JSM has received research funding from Alcon , Allergan , Glaukos , Inotek , and Merck ; consultant fees from Aerie , Alcon , Allergan , Inotek , and Sucampo ; and lecture fees from Alcon , Allergan , and Sucampo .", "", "<http://ctro/data#EvidenceQuality_95508> <http://ctro/data#hasConflictInterest> \"JSM has received research funding from Alcon , Allergan , Glaukos , Inotek , and Merck ; consultant fees from Aerie , Alcon , Allergan , Inotek , and Sucampo ; and lecture fees from Alcon , Allergan , and Sucampo .\"."
88, ConflictInterest, 2935, 2961, "DAH is an Alcon employee .", "", "<http://ctro/data#EvidenceQuality_95508> <http://ctro/data#hasConflictInterest> \"DAH is an Alcon employee .\"."
90, ConflictInterest, 2962, 2965, "DLB", "", "<http://ctro/data#EvidenceQuality_95508> <http://ctro/data#hasConflictInterest> \"DLB\"."
89, ConflictInterest, 2966, 3218, "has received consultant fees from Alcon and Ivantis , and research support from the National Eye Institute , Glaucoma Research Foundation , Research to Prevent Blindness , and New World Medical , Inc . HBD has received speakers bureau fees from Alcon .", "", "<http://ctro/data#EvidenceQuality_95508> <http://ctro/data#hasConflictInterest> \"has received consultant fees from Alcon and Ivantis , and research support from the National Eye Institute , Glaucoma Research Foundation , Research to Prevent Blindness , and New World Medical , Inc . HBD has received speakers bureau fees from Alcon .\"."
